-
Current package labeling for the contraceptive injection depot medroxyprogesterone acetate (DMPA) (Depo-Provera, Pfizer, New York City) calls for the method to be initiated within the first five days of a womans menstrual period.
-
The next patient at your STD (sexually transmitted diseases) clinic is a young man with a mucoid/purulent anal discharge and a lymph node enlargement in the groin area.
-
While no microbicide has yet moved from the research pipeline to the pharmacy shelf, progress is going forward on several fronts to develop female-controlled physical and chemical barrier methods to prevent HIV and other sexually transmitted diseases (STDs).
-
While the decision to make emergency contraception (EC) available over the counter remains in a holding pattern at the Food and Drug Administration, advocates are moving on the state level to allow pharmacists to dispense EC without a physicians prescription under certain conditions.
-
Scientists are preparing to take the next step in the search for a spray-on contraceptive, with a Phase II trial scheduled for the second half of 2006.
-
If it does not, what will it take to integrate an immunization program into existing services? Take a tip from the Internet. Consult the online guide, Hepatitis B Immunization in a STD Clinic: Lessons Learned in San Diego County.
-
Women with inactive or stable systemic lupus erythematosus a disease in which the bodys immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs need effective contraception When women with inactive or stable systemic lupus erythematosus need effective contraception, clinicians rarely prescribe oral contraceptives (OCs) due to fears that the Pill might increase disease activity.
-
The last patient on your list is a young woman with a positive test for a sexually transmitted disease (STD). When discussing strategies for protection from future infections, she tells you she is not comfortable with using a female condom and has problems negotiating male condom use with her boyfriend. Outside of abstinence, what are her options?
-
When discussing prevention strategies against sexually transmitted diseases (STDs) with your patients, do you discuss immunization against hepatitis B? The message may not be getting through; 42% of 1,150 adults ages 18-35 participating in a 2004 national survey did not know they could protect themselves from hepatitis B virus (HBV) infection through vaccination.
-
Contraceptive use has been reported as a risk factor for cervical cancer; however, since the discovery of the strong link between human papillomavirus (HPV) infection and cervical cancer, evidence has been unclear on its association.
